Cigna Group
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
CI$295.60+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
FS-2
STATEMENTS OF INCOME
| For the Years Ended December 31, | |||
|---|---|---|---|
| (In millions) | 2024 | 2023 | 2022 |
| Revenues | |||
| Net investment income and other revenue | $26 | $22 | $5 |
| Intercompany interest income | 469 | 516 | 478 |
| Total revenues | 495 | 538 | 483 |
| Operating expenses | |||
| Selling, general and administrative expenses | 14 | 2 | 2 |
| Total operating expenses | 14 | 2 | 2 |
| Income from operations | 481 | 536 | 481 |
| Interest expense and other | (1,388) | (1,332) | (1,215) |
| Intercompany interest expense | (2) | (118) | (147) |
| Loss before income taxes | (909) | (914) | (881) |
| Income tax benefits | (189) | (192) | (183) |
| Loss of parent company | (720) | (722) | (698) |
| Equity in income of subsidiaries | 4,154 | 5,886 | 7,402 |
| Shareholders' net income | 3,434 | 5,164 | 6,704 |
| Shareholders' other comprehensive income (loss), net of tax | |||
| Net unrealized appreciation (depreciation) on securities and derivatives | 661 | 503 | (1,598) |
| Net long-duration insurance and contractholder liabilities measurement adjustments | (1,067) | (715) | 509 |
| Net translation (losses) gains of foreign currencies | (49) | 5 | 79 |
| Postretirement benefits liability adjustment | (22) | 1 | 420 |
| Shareholders' other comprehensive loss, net of tax | (477) | (206) | (590) |
| Shareholders' comprehensive income | $2,957 | $4,958 | $6,114 |
FS-2
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.